Impact of Helicobacter pylori Infection on Serum Lipid Profile and Atherosclerosis of Carotid Artery


Background: Helicobacter pylori (H. pylori) infection has been suggested to be associated with atherosclerosis. The issue is still controversial. It is well known that abnormal lipid profile is related to atherosclerosis and measurement of carotid intima-media thickness. Aim of the study: to investigate carotid intima-media thickness and lipid parameters in H. pylori-positive and -negative subjects. Materials & Methods: This study was conducted in Kurdistan Teaching center of Gastroenterology and Hepatology (KCGH) in Sulaimani city during the period of December 2012 to March 2014. One hundred dyspeptic patients with H. pylori infection and 74 apparently healthy asymptomatic volunteers with H. pylori-negative tests were enrolled in this study. Both groups were comparable in age distribution and gender. H. pylori infection (IgG & IgA) were assessed by ELISA tests, Triglyceride, total cholesterol, low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) concentrations were measured by routine enzymatic methods using commercial kits. Carotid intima-media thickness was assessed by high-resolution ultrasound. Results: The mean and maximum values of internal and common carotid intima-media thickness in H. pylori-positive subjects were significantly thicker than in H. pylori-negative subjects (p < 0.05). HDL-C level was lower in patients (H. pylori seropositive) than in controls (seronegative subjects), total cholesterol, LDL-C and triglyceride level were found to be higher in patients than in controls (p < 0.01). Conclusions: Carotid intima-media thickness as well as all lipid values apart from HDL-C was increased in H. pylori-positive subjects. These data indicated that H. pylori infection may had a role in atherosclerotic process.

Share and Cite:

Ibrahim, H. , Mohammed, M. , Dhahir, H. , Mahmood, K. and Nuradeen, B. (2014) Impact of Helicobacter pylori Infection on Serum Lipid Profile and Atherosclerosis of Carotid Artery. International Journal of Clinical Medicine, 5, 933-939. doi: 10.4236/ijcm.2014.515125.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Eckardstein, A.V. (2004) Is There a Need for Novel Cardiovascular Risk Factors? Nephrology Dialysis Transplantation, 19, 761-765.
[2] Greenland, P., Knoll, M.D. and Stamler, J. (2003) Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events. JAMA, 290, 891-897.
[3] Kastelein, J.J., Wiegman, A. and Groot, E. (2003) Surrogate Markers of Atherosclerosis: Impact of Statins. Atherosclerosis Supplements, 4, 31-36.
[4] Watt, S., Aesch, B., Lanotte, P., Tranquart, F. and Quentin, R. (2003) Viral and bacterial DNA in Carotid Atherosclerotic Lesions. European Journal of Clinical Microbiology & Infectious Diseases, 22, 99-105.
[5] Hamed, S.A., Amine, N.F., Galal, G.M., Helal, S.R., El-Din, L.M.T., Shawky, O.A., et al. (2008) Vascular Risks and Complications in Diabetes Mellitus. The Role of Helicobacter pylori Infection. Journal of Stroke & Cerebrovascular Diseases, 17, 86-94.
[6] Cammaroat, G., Pasceri, V., Gasbarrini, A. and Gabarrini, G. (2000) Helicobacter pylori Is an Aetiologic Factor for Ischaemic Heart Disease: The Case against. Digestive and Liver Disease, 32, 65-68.
[7] Franceschi, F., Navarese, E.P., Mollo, R., Giupponi, B., De Marco, G., Merra, G., Gasbarrini, G. and Silveri, N.G. (2009) Helicobacter pylori and Atherosclerosis. A Review of the Literature. Recenti Progressi in Medicina, 100, 91-96.
[8] Gen, R., Demir, M. and Ataseven, H. (2010) Effect of Helicobacter pylori Eradication on Insulin Resistance, Serum Lipids and Low-Grade Inflammation. Southern Medical Journal, 103, 190-196.
[9] Khairy, P., Rinfret, S., Tardif, J.C., Marchand, R., Shapiro, S., Brophy, J., et al. (2003) Absence of Association between Infectious Agents and Endothelial Function in Healthy Young Men. Circulation, 107, 1966-1971.
[10] Chimienti, G., Russo, F. and Lamanuzzi, B.L. (2003) Helicobacter pylori Is Associated with Modified Lipid Profile: Impact on Lipoprotein (a). Clinical Biochemistry, 36, 359-365.
[11] Asano, K., Kubo, M., Yonemoto, K., Doi, Y., Ninomiya, T., Tanizaki, Y., et al. (2008) Impact of Serum Total Cholestrol on the Incidence of Gastric Cancer in a Population-Based Prospective Study: The Hisayama Study. International Journal of Cancer, 122, 909-914.
[12] Buzás, G.M. (2014) Metabolic Consequences of Helicobacter pylori Infection and Eradication. World Journal of Gastroenterology, 20, 5226-5234.
[13] Pellicano, R., Broutet, N., Ponzetto, A. and Mégraud, F. (1999) Helicobacter pylori: From the Stomach to the Heart. European Journal of Gastroenterology & Hepatology, 11, 1335-1337.
[14] Jia, E.Z., Zhao, F.J., Hao, B., Zhu, T.B., Wang, L.S., Chen, B., et al. (2009) Helicobacter pylori Infection Is Associated with Decreased Serum Levels of High Density Lipoprotein, but Not with the Severity of Coronary Atherosclerosis. Lipids in Health and Disease, 8, 59.
[15] Hoffmeister, A., Rothenbacher, D., Bode, G., Persson, K., März, W., Nauck, M.A., et al. (2001) Current Infection with Helicobacter pylori, but Not Seropositivity to Chlamydia pneumonia or Cytomegalovirus, Is Associated with Atherogenic, Modified Lipid Profile. Arteriosclerosis, Thrombosis, and Vascular Biology, 21, 427-432.
[16] Mackness, M., Durrington, P. and Mackness, B. (2004) Paraoxonase 1 Activity, Concentration and Genotype in Cardiovascular Disease. Current Opinion in Lipidology, 15, 399-404.
[17] Georges, J.L., Rupprecht, H.J., Blankenberg, S., Poirier, O., Bickel, C., Hafner, G., et al. (2003) Impact of Pathogen Burden in Patients with Coronary Artery Disease in Relation to Systemic Inflammation and Variation in Genes Encoding Cytokines. American Journal of Cardiology, 92, 515-521.
[18] Karpouza, A., Samouilidou, E., Karagiannis, S., Kostopoulou, V., Sotiropoulou, M., Roma, E., et al. (2008) Patients with Duodenal Ulcer Have Lower Levels of Serum Cholesterol Compared to Other Dyspeptic Patients Independently of Helicobacter pylori Status. Scandinavian Journal of Gastroenterology, 43, 922-928.
[19] Kucukazman, M., Yavuz, B., Sacikara, M., Asilturk, Z., Ata, N., Ertugrul, D.T., et al. (2009) The Relationship between Updated Sydney System Score and LDL Cholesterol Levels in Patients Infected with Helicobacter pylori. Digestive Diseases and Sciences, 54, 604-607.
[20] Satoh, H., Saijo, Y., Yoshioka, E. and Tsutsui, H. (2010) Helicobacter Pylori Infection Is a Significant Risk for Modified Lipid Profile in Japanese Male Subjects. Journal of Atherosclerosis and Thrombosis, 17, 1041-1048.
[21] Kim, H.L., Jeon, H.H., Park, I.Y., Choi, J.M., Kang, J.S. and Min, K.W. (2011) Helicobacter pylori Infection Is Associated with Elevated Low Density Lipoprotein Cholesterol Levels in Elderly Koreans. Journal of Korean Medical Science, 26, 654-658.
[22] Akbas, H.S., Basyigit, S., Suleymanlar, I., Kemaloglu, D., Koc, S., Davran, F., et al. (2010) The Assessment of Carotid Intima Media Thickness and Serum Paraoxonase-1 Activity in Helicobacter pylori Positive Subjects. Lipids in Health and Disease, 9, 92.
[23] Feingold, K.R., Hardardottir, I., Memon, R., Krul, E.J., Moser, A.H., Taylor, J.M., et al. (1993) Effect of Endotoxin on Cholesterol Biosynthesis and Distribution in Serum Lipoproteins in Syrian Hamsters. Journal of Lipid Research, 34, 2147-2158.
[24] Volanen, I., Raitakari, O.T., Vainionpää, R., Arffman, M., Aarnisalo, J., Anglé, S., et al. (2005) Serum Lipid Profiles Poorly Correlate with Chlamydia Pneumoniae, Helicobacter pylori, and Cytomegalovirus Seropositivity in Prospectively Followed-Up Healthy Children. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 827-832.
[25] Gupta, N., Saigal, R., Goyal, L., Agrawal, A., Bhargava, R. and Agrawal, A. (2014) Carotid Intima Media Thickness as a Marker of Atherosclerosis in Ankylosing Spondylitis. International Journal of Rheumatology, 2014, Article ID: 839135.
[26] Katakami, N., Kaneto, H. and Shimomura, I. (2014) Carotid Ultrasonography: A Potent Tool for Better Clinical Practice in Diagnosis of Atherosclerosis in Diabetic Patients. Journal of Diabetes Investigation, 5, 3-13.
[27] Altintas, E., Ucbilek, E., Ulu, O., Sezgin, O., Uzer, C., Tataroglu, C. and Camdeviren, H. (2007) Helicobacter pylori-Associated Atrophic Gastritis and Carotid Intima-Media Thickness, Is There a Link? International Journal of Clinical Practice, 61, 810-814.
[28] Folsom, A.R., Nieto, F.J., Sorlie, P., Chambless, L.E. and Graham, D.Y. (1998) Helicobacter pylori Seropositivity and Coronary Heart Disease Incidence. Circulation, 98, 845-850.
[29] Mete, R., Oran, M., Alpsoy, S., Gunes, H., Tulubas, F., Turan, C., et al. (2013) Carotid Intima-Media Thickness and Serum Paraoxonase-1 Activity in Patients with Helicobacter pylori. European Review for Medical and Pharmacological Sciences, 17, 2884-2889.
[30] Kanbay, M., Gür, G., Yücel, M., Yilmaz, U. and Boyacioglu S. (2005) Does Eradication of Helicobacter pylori Infection Help Normalize Serum Lipid and CRP Levels? Digestive Diseases and Sciences, 50, 1228-1231.
[31] Van Lent, F. (2000) Markers of Inflammation as Predictors in Cardiovascular Disease. Clinica Chimica Acta, 293, 31-52.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.